In 1818 was created Landesbank Baden Wurttemberg, which is appeared as Corporate Investor. The company was established in Europe in Germany. The leading representative office of defined Corporate Investor is situated in the Stuttgart.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are SaaS, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight BrandMaker. Besides, a startup needs to be aged 16-20 years to get the investment from the fund.
The top activity for fund was in 2018. Comparing to the other companies, this Landesbank Baden Wurttemberg performs on 4 percentage points more the average number of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year.
The standard case for the fund is to invest in rounds with 3 partakers. Despite the Landesbank Baden Wurttemberg, startups are often financed by eCAPITAL entrepreneurial Partners AG, Nextech Invest, S-Kap Unternehmensbeteiligungs. The meaningful sponsors for the fund in investment in the same round are Future Capital, eCAPITAL entrepreneurial Partners AG, VI Partners AG. In the next rounds fund is usually obtained by Future Capital, MIG AG, VI Partners AG.
Related Funds
| Fund Name | Location |
| Adani Ports | Ahmedabad, Gujarat, India |
| Black Fish | China, Jiangsu, Nanjing |
| Blockchain Ventures | California, Palo Alto, United States |
| Direct Line Insurance | Bromley, England, United Kingdom |
| Dolma Impact Fund | Ebène, Mauritius, Plaines Wilhems |
| French IoT | - |
| Haddad Advisory | - |
| Herrikoa | Anglet, Aquitaine, France |
| JBV Capital | California, San Francisco, United States |
| Lanai Partners | Barcelona, Catalonia, Spain |
| Maxim Group | New York, New York, United States |
| One Mind Brain Health Impact Fund | - |
| Portage Partners | New York, New York, United States |
| Rowny Capital | District of Columbia, United States, Washington |
| Sprint | Kansas, Overland Park, United States |
| Sutardja Ventures | - |
| TSARI Capital | - |
| UK Innovation & Science Seed Fund | Harwell, Oxfordshire, United Kingdom |
| Winrock International | Arkansas, Little Rock, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Swiat | 26 Jan 2023 | Frankfort, Maine, United States | |||
| $12M | 22 Apr 2021 | Berlin, Berlin, Germany | |||
BrandMaker | 27 Jun 2018 | Atlanta, Georgia, United States | |||
Ganymed Pharmaceuticals | $39M | 24 Sep 2007 | Mainz, Rhineland-Palatinate, Germany | ||
Ganymed Pharmaceuticals | $14M | 06 Jul 2005 | Mainz, Rhineland-Palatinate, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Swiat | 26 Jan 2023 | Frankfort, Maine, United States | |||
| $12M | 22 Apr 2021 | Berlin, Berlin, Germany | |||
BrandMaker | 27 Jun 2018 | Atlanta, Georgia, United States | |||
Ganymed Pharmaceuticals | $39M | 24 Sep 2007 | Mainz, Rhineland-Palatinate, Germany | ||
Ganymed Pharmaceuticals | $14M | 06 Jul 2005 | Mainz, Rhineland-Palatinate, Germany |
